The glycolytic enzyme aldolase C is up-regulated in rat forebrain microsomes and in the cerebrospinal fluid after repetitive fluoxetine treatment

Mauricio Sandoval; Alejandro Luarte; Rodrigo Herrera-Molina; Manuel Varas-Godoy; Marcos Santibáñez; Francisco J. Rubio; August B. Smit; Eckart D. Gundelfinger; Ka Wan Li; Karl Heinz Smalla; Ursula Wyneken

doi:10.1016/j.brainres.2013.04.049

The glycolytic enzyme aldolase C is up-regulated in rat forebrain microsomes and in the cerebrospinal fluid after repetitive fluoxetine treatment

Mauricio Sandoval, Alejandro Luarte, Rodrigo Herrera-Molina, Manuel Varas-Godoy, Marcos Santibáñez, Francisco J. Rubio, August B. Smit, Eckart D. Gundelfinger, Ka Wan Li, Karl Heinz Smalla, Ursula Wyneken^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

The antidepressant drug fluoxetine is widely used for the treatment of a broad range of psychiatric disorders. Its mechanism of action is thought to involve cellular adaptations that are induced with a slow time course after initiation of treatment. To gain insight into the signaling pathways underlying such changes, the expression levels of proteins in a microsomal sub-fraction enriched in intracellular membranes from the rat forebrain was analyzed after two weeks of treatment with fluoxetine. Proteins were separated by two-dimensional gel electrophoresis, and the differentially regulated protein spots were identified by mass spectrometry. Protein network analysis suggested that most of the identified proteins could potentially be regulated by the insulin family of proteins. Among them, Fructose-bisphosphate aldolase C (AldoC), a glycolytic/gluconeogenic enzyme primarily expressed in forebrain astrocytes, was up-regulated 7.6-fold. An immunohistochemical analysis of the dorsal hippocampus revealed a robust decrease (43±2%) in the co-localization of AldoC and the astrocyte marker GFAP and a diffuse staining pattern, compatible with AldoC secretion into the extracellular space. Consistently, AldoC, contained in an exosome-like fraction in astrocyte conditioned medium, increased significantly in the cerebrospinal fluid. Our findings strongly favor a non-canonic signaling role for AldoC in cellular adaptations induced by repetitive fluoxetine treatment.

Original language	English
Pages (from-to)	1-14
Number of pages	14
Journal	Brain Research
Volume	1520
DOIs	https://doi.org/10.1016/j.brainres.2013.04.049
State	Published - 3 Jul 2013

Bibliographical note

Funding Information:
We are grateful to Soledad Sandoval for technical assistance. This work was supported by Conicyt (Postdoctoral Fondecyt Project 3100057 to MS), Deutsche Forschungsgemeinschaft (SM38/8-1 to UW and KHS), the Federal State of Saxony-Anhalt and the “European Regional Development Fund” (ERDF 2007–2013) (EDG, KHS), Conicyt and BMBF (CHL 06/027 to UW and KHS) and the Initiative for Research and Innovation of the Leibniz Association (EDG). RHM and MS thank the International Society for Neurochemistry and the Committee for Aid and Education in Neurochemistry (CAEN) for financial support.

Keywords

Antidepressants
Exosomes
Mass spectrometry
Signaling networks
Sub-cellular fractionation

Access to Document

10.1016/j.brainres.2013.04.049

Cite this

Sandoval, M., Luarte, A., Herrera-Molina, R., Varas-Godoy, M., Santibáñez, M., Rubio, F. J., Smit, A. B., Gundelfinger, E. D., Li, K. W., Smalla, K. H., & Wyneken, U. (2013). The glycolytic enzyme aldolase C is up-regulated in rat forebrain microsomes and in the cerebrospinal fluid after repetitive fluoxetine treatment. Brain Research, 1520, 1-14. https://doi.org/10.1016/j.brainres.2013.04.049

@article{df3fb5be6dd54a179d85791743ee57b8,

title = "The glycolytic enzyme aldolase C is up-regulated in rat forebrain microsomes and in the cerebrospinal fluid after repetitive fluoxetine treatment",

abstract = "The antidepressant drug fluoxetine is widely used for the treatment of a broad range of psychiatric disorders. Its mechanism of action is thought to involve cellular adaptations that are induced with a slow time course after initiation of treatment. To gain insight into the signaling pathways underlying such changes, the expression levels of proteins in a microsomal sub-fraction enriched in intracellular membranes from the rat forebrain was analyzed after two weeks of treatment with fluoxetine. Proteins were separated by two-dimensional gel electrophoresis, and the differentially regulated protein spots were identified by mass spectrometry. Protein network analysis suggested that most of the identified proteins could potentially be regulated by the insulin family of proteins. Among them, Fructose-bisphosphate aldolase C (AldoC), a glycolytic/gluconeogenic enzyme primarily expressed in forebrain astrocytes, was up-regulated 7.6-fold. An immunohistochemical analysis of the dorsal hippocampus revealed a robust decrease (43±2%) in the co-localization of AldoC and the astrocyte marker GFAP and a diffuse staining pattern, compatible with AldoC secretion into the extracellular space. Consistently, AldoC, contained in an exosome-like fraction in astrocyte conditioned medium, increased significantly in the cerebrospinal fluid. Our findings strongly favor a non-canonic signaling role for AldoC in cellular adaptations induced by repetitive fluoxetine treatment.",

keywords = "Antidepressants, Exosomes, Mass spectrometry, Signaling networks, Sub-cellular fractionation, Antidepressants, Exosomes, Mass spectrometry, Signaling networks, Sub-cellular fractionation",

author = "Mauricio Sandoval and Alejandro Luarte and Rodrigo Herrera-Molina and Manuel Varas-Godoy and Marcos Santib{\'a}{\~n}ez and Rubio, {Francisco J.} and Smit, {August B.} and Gundelfinger, {Eckart D.} and Li, {Ka Wan} and Smalla, {Karl Heinz} and Ursula Wyneken",

note = "Funding Information: We are grateful to Soledad Sandoval for technical assistance. This work was supported by Conicyt (Postdoctoral Fondecyt Project 3100057 to MS), Deutsche Forschungsgemeinschaft (SM38/8-1 to UW and KHS), the Federal State of Saxony-Anhalt and the “European Regional Development Fund” (ERDF 2007–2013) (EDG, KHS), Conicyt and BMBF (CHL 06/027 to UW and KHS) and the Initiative for Research and Innovation of the Leibniz Association (EDG). RHM and MS thank the International Society for Neurochemistry and the Committee for Aid and Education in Neurochemistry (CAEN) for financial support. ",

year = "2013",

month = jul,

day = "3",

doi = "10.1016/j.brainres.2013.04.049",

language = "English",

volume = "1520",

pages = "1--14",

journal = "Brain Research",

issn = "0006-8993",

publisher = "Elsevier",

}

Sandoval, M, Luarte, A, Herrera-Molina, R, Varas-Godoy, M, Santibáñez, M, Rubio, FJ, Smit, AB, Gundelfinger, ED, Li, KW, Smalla, KH & Wyneken, U 2013, 'The glycolytic enzyme aldolase C is up-regulated in rat forebrain microsomes and in the cerebrospinal fluid after repetitive fluoxetine treatment', Brain Research, vol. 1520, pp. 1-14. https://doi.org/10.1016/j.brainres.2013.04.049

TY - JOUR

T1 - The glycolytic enzyme aldolase C is up-regulated in rat forebrain microsomes and in the cerebrospinal fluid after repetitive fluoxetine treatment

AU - Sandoval, Mauricio

AU - Luarte, Alejandro

AU - Herrera-Molina, Rodrigo

AU - Varas-Godoy, Manuel

AU - Santibáñez, Marcos

AU - Rubio, Francisco J.

AU - Smit, August B.

AU - Gundelfinger, Eckart D.

AU - Li, Ka Wan

AU - Smalla, Karl Heinz

AU - Wyneken, Ursula

N1 - Funding Information: We are grateful to Soledad Sandoval for technical assistance. This work was supported by Conicyt (Postdoctoral Fondecyt Project 3100057 to MS), Deutsche Forschungsgemeinschaft (SM38/8-1 to UW and KHS), the Federal State of Saxony-Anhalt and the “European Regional Development Fund” (ERDF 2007–2013) (EDG, KHS), Conicyt and BMBF (CHL 06/027 to UW and KHS) and the Initiative for Research and Innovation of the Leibniz Association (EDG). RHM and MS thank the International Society for Neurochemistry and the Committee for Aid and Education in Neurochemistry (CAEN) for financial support.

PY - 2013/7/3

Y1 - 2013/7/3

N2 - The antidepressant drug fluoxetine is widely used for the treatment of a broad range of psychiatric disorders. Its mechanism of action is thought to involve cellular adaptations that are induced with a slow time course after initiation of treatment. To gain insight into the signaling pathways underlying such changes, the expression levels of proteins in a microsomal sub-fraction enriched in intracellular membranes from the rat forebrain was analyzed after two weeks of treatment with fluoxetine. Proteins were separated by two-dimensional gel electrophoresis, and the differentially regulated protein spots were identified by mass spectrometry. Protein network analysis suggested that most of the identified proteins could potentially be regulated by the insulin family of proteins. Among them, Fructose-bisphosphate aldolase C (AldoC), a glycolytic/gluconeogenic enzyme primarily expressed in forebrain astrocytes, was up-regulated 7.6-fold. An immunohistochemical analysis of the dorsal hippocampus revealed a robust decrease (43±2%) in the co-localization of AldoC and the astrocyte marker GFAP and a diffuse staining pattern, compatible with AldoC secretion into the extracellular space. Consistently, AldoC, contained in an exosome-like fraction in astrocyte conditioned medium, increased significantly in the cerebrospinal fluid. Our findings strongly favor a non-canonic signaling role for AldoC in cellular adaptations induced by repetitive fluoxetine treatment.

AB - The antidepressant drug fluoxetine is widely used for the treatment of a broad range of psychiatric disorders. Its mechanism of action is thought to involve cellular adaptations that are induced with a slow time course after initiation of treatment. To gain insight into the signaling pathways underlying such changes, the expression levels of proteins in a microsomal sub-fraction enriched in intracellular membranes from the rat forebrain was analyzed after two weeks of treatment with fluoxetine. Proteins were separated by two-dimensional gel electrophoresis, and the differentially regulated protein spots were identified by mass spectrometry. Protein network analysis suggested that most of the identified proteins could potentially be regulated by the insulin family of proteins. Among them, Fructose-bisphosphate aldolase C (AldoC), a glycolytic/gluconeogenic enzyme primarily expressed in forebrain astrocytes, was up-regulated 7.6-fold. An immunohistochemical analysis of the dorsal hippocampus revealed a robust decrease (43±2%) in the co-localization of AldoC and the astrocyte marker GFAP and a diffuse staining pattern, compatible with AldoC secretion into the extracellular space. Consistently, AldoC, contained in an exosome-like fraction in astrocyte conditioned medium, increased significantly in the cerebrospinal fluid. Our findings strongly favor a non-canonic signaling role for AldoC in cellular adaptations induced by repetitive fluoxetine treatment.

KW - Antidepressants

KW - Exosomes

KW - Mass spectrometry

KW - Signaling networks

KW - Sub-cellular fractionation

KW - Antidepressants

KW - Exosomes

KW - Mass spectrometry

KW - Signaling networks

KW - Sub-cellular fractionation

UR - http://www.scopus.com/inward/record.url?scp=84879134259&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2013.04.049

DO - 10.1016/j.brainres.2013.04.049

M3 - Article

C2 - 23688545

AN - SCOPUS:84879134259

SN - 0006-8993

VL - 1520

SP - 1

EP - 14

JO - Brain Research

JF - Brain Research

ER -

The glycolytic enzyme aldolase C is up-regulated in rat forebrain microsomes and in the cerebrospinal fluid after repetitive fluoxetine treatment

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this